Collins: Twenty Years of Citation
The announcement on July 8, 2009, that President Obama had
nominated Francis S. Collins to be the director of the National
Institutes of Health was greeted by broad acclaim from the
scientific community and other quarters. Although Dr. Collins may
be best known for his leadership role in the Human Genome Project,
his distinguished career as a physician and geneticist goes back
The table below lists 10 highly cited papers, published since 1989,
to which Dr. Collins contributed. Prominent are the large,
multiauthor reports on the human and mouse genomes, as well as
earlier papers examining the genetics of cystic fibrosis,
Huntington’s disease, cancer, and other disorders. For
additional biographical details on Dr. Collins and an extensive
list of his publications, go to
International Human Genome Sequencing Consortium
(E.S. Lander, et al.), "Initial sequencing
and analysis of the human genome," Nature,
409(6822): 860-921, 2001.
J.R. Riordan, et al., "Identification of
the cystic fibrosis gene: Cloning and
characterization of complementary DNA,"
Science, 245(4922): 1066-72, 1989.
Mouse Genome Sequencing Consortium (R.H. Waterston,
et al.), "Initial sequencing and
comparative analysis of the mouse genome,"
Nature, 420(6915): 520-62, 2002.
M.E. MacDonald, et al., "A novel gene
containing a trinucleotide repeat that is expanded
and unstable on Huntington’s disease
chromosomes," Cell, 72(6): 971-83, 1993.
J.M. Rommens, et al., "Identification of
the cystic fibrosis gene: Chromosome walking and
jumping," Science, 245(4922): 1059-65,
International HapMap Consortium, (D. Altshuler,
et al.), "A haplotype map of the human
genome," Nature, 437(7063): 1299-1320,
K. Savitsky, et al., "A single ataxia
telangiectasia gene with a product similar to PI-3
kinase," Science, 268(5218): 1749-53,
International HapMap Consortium (R.A. Gibbs, et
al.), "The International HapMap Project,"
Nature, 426(6968): 789-96, 2003.
D. Marchuk, et al., "Construction of
T-vectors, a rapid and general system for direct
cloning of unmodified PCR products," Nucleic
Acids Research, 19(5): 1154, 1991.
D. Ford, et al., "Risks of cancer in
BRCA-1 mutation carriers," Lancet,
343(8899): 692-5, 1994.